Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Chimeric Allografts Induced by Short-Term Treatment with Stem Cell Mobilizing Agents Result in Long-term Kidney Transplant Survival without Immunosuppression: II Study in Miniature Swine.

Cameron AM, Wesson R, Ahmadi A, Singer AL, Hu X, Okabayashi T, Wang Y, Shigoka M, Fu Y, Gao W, Raccusen LC, Montgomery RA, Williams GM, Sun Z.

Am J Transplant. 2016 Jan 8. doi: 10.1111/ajt.13703. [Epub ahead of print]

PMID:
26748958
2.

Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation.

Batra RK, Heilman RL, Smith ML, Thomas LF, Khamash HA, Katariya NN, Hewitt WR, Singer AL, Mathur AK, Huskey J, Chakkera HA, Moss A, Reddy KS.

Am J Transplant. 2016 Mar;16(3):1015-20. doi: 10.1111/ajt.13561. Epub 2015 Dec 21.

PMID:
26689853
3.

Glucose homeostasis after simultaneous pancreas and kidney transplantation: a comparison of subjects with C-peptide-positive non-type 1 diabetes mellitus and type 1 diabetes mellitus.

Chakkera HA, Kudva YC, Chang YH, Heilman RL, Singer AL, Mathur AK, Hewitt WR, Khamash HA, Huskey JL, Katariya NN, Moss AA, Behmen S, Reddy KS.

Clin Transplant. 2016 Jan;30(1):52-9. doi: 10.1111/ctr.12658. Epub 2015 Nov 26.

PMID:
26485408
4.

Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation.

Lonze BE, Zachary AA, Magro CM, Desai NM, Orandi BJ, Dagher NN, Singer AL, Carter-Monroe N, Nazarian SM, Segev DL, Streiff MB, Montgomery RA.

Am J Transplant. 2014 Feb;14(2):459-65. doi: 10.1111/ajt.12540. Epub 2014 Jan 8.

5.

Kidney Transplant Program at the Mayo Clinic in Arizona.

Heilman RL, Khamash HA, Huskey JL, Chakkera HA, Batra RK, Katariya NN, Singer AL, Mathur AK, Moss AA, Reddy KS.

Clin Transpl. 2014:61-8.

PMID:
26281128
6.

Transplantation: Alloantibodies in simultaneous liver-kidney transplantation.

Singer AL, Segev DL.

Nat Rev Nephrol. 2013 Jul;9(7):373-4. doi: 10.1038/nrneph.2013.84. Epub 2013 May 7. No abstract available.

PMID:
23649019
7.

Identifying appropriate recipients for CDC infectious risk donor kidneys.

Chow EK, Massie AB, Muzaale AD, Singer AL, Kucirka LM, Montgomery RA, Lehmann HP, Segev DL.

Am J Transplant. 2013 May;13(5):1227-34. doi: 10.1111/ajt.12206.

8.

Reply to "Defining the benefits of desensitization therapy".

Singer AL, Alachkar N, Montgomery RA, Zachary AA.

Transplantation. 2013 Mar 27;95(6):e33. doi: 10.1097/TP.0b013e3182845ffb. No abstract available.

PMID:
23507652
9.

The aggressive phenotype revisited: utilization of higher-risk liver allografts.

Garonzik-Wang JM, James NT, Van Arendonk KJ, Gupta N, Orandi BJ, Hall EC, Massie AB, Montgomery RA, Dagher NN, Singer AL, Cameron AM, Segev DL.

Am J Transplant. 2013 Apr;13(4):936-42. doi: 10.1111/ajt.12151. Epub 2013 Feb 15.

10.

Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.

Alachkar N, Lonze BE, Zachary AA, Holechek MJ, Schillinger K, Cameron AM, Desai NM, Dagher NN, Segev DL, Montgomery RA, Singer AL.

Transplantation. 2012 Jul 27;94(2):165-71. doi: 10.1097/TP.0b013e318253f7b6.

PMID:
22735712
11.

Rescue kidney paired donation as emergency salvage for failed desensitization.

Sharif A, Zachary AA, Hiller J, Segev D, Alachkar N, Kraus ES, Desai NM, Dagher NN, Singer AL, Montgomery RA.

Transplantation. 2012 Apr 15;93(7):e27-9. doi: 10.1097/TP.0b013e318249b10e. No abstract available.

PMID:
22450596
12.

Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis.

Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Cameron AM, Singer AL, Dagher NN, Segev DL.

Liver Transpl. 2012 Jun;18(6):621-9. doi: 10.1002/lt.23416. Review.

13.

Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.

Lonze BE, Dagher NN, Liu M, Kucirka LM, Simpkins CE, Locke JE, Desai NM, Cameron AM, Montgomery RA, Segev DL, Singer AL.

Arch Surg. 2011 Nov;146(11):1261-6. doi: 10.1001/archsurg.2011.267.

PMID:
22106317
14.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

15.

Estimating the potential pool of HIV-infected deceased organ donors in the United States.

Boyarsky BJ, Hall EC, Singer AL, Montgomery RA, Gebo KA, Segev DL.

Am J Transplant. 2011 Jun;11(6):1209-17. doi: 10.1111/j.1600-6143.2011.03506.x. Epub 2011 Mar 28.

16.

High infectious risk donors: what are the risks and when are they too high?

Kucirka LM, Singer AL, Segev DL.

Curr Opin Organ Transplant. 2011 Apr;16(2):256-61. doi: 10.1097/MOT.0b013e3283449dd3. Review.

PMID:
21415830
17.

Outcomes and discard of kidneys from pediatric donors after cardiac death.

Dagher NN, Lonze BE, Singer AL, Simpkins CE, Desai NM, Montgomery RA, Segev DL.

Transplantation. 2011 Apr 15;91(7):765-71. doi: 10.1097/TP.0b013e31820cfd27.

PMID:
21285917
18.

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.

Locke JE, Singer AL.

Hepat Med. 2011 May 13;3:53-62. doi: 10.2147/HMER.S13682. Review.

19.

Improving distribution efficiency of hard-to-place deceased donor kidneys: Predicting probability of discard or delay.

Massie AB, Desai NM, Montgomery RA, Singer AL, Segev DL.

Am J Transplant. 2010 Jul;10(7):1613-20. doi: 10.1111/j.1600-6143.2010.03163.x.

20.

Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.

Lonze BE, Dagher NN, Simpkins CE, Locke JE, Singer AL, Segev DL, Zachary AA, Montgomery RA.

Am J Transplant. 2010 Sep;10(9):2154-60. doi: 10.1111/j.1600-6143.2010.03191.x. Epub 2010 Jul 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk